Blu – Pagina 39 – AMD

Blu

Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.

Novembre 13, 2025 Alice Lione

Lantidra (donislecel) in type 1 diabetes: an in-depth analysis of pharmacology, clinical effectiveness, safety, and the therapeutic role of the first FDA-approved allogeneic islet cell therapy

Erbasan E, Aliciaslan M, Erendor F, et al.
Diabet Med. Pub. online 11 Nov 2025.

Leggi

Novembre 13, 2025 Alice Lione

Associations between gestational diabetes and cardiovascular disease largely operate independently of postpartum causal pathways: a population-based cohort study in England

Astbury NM, Ripullone K, Ramakrishnan R, et al.
Diabetes Obes Metab. Pub. online 5 Nov 2025.

Leggi

Novembre 13, 2025 Alice Lione

Amylin and the renin-angiotensin system: risk or opportunity in amylin-based therapy?

Muskiet MHA, Nardone M, Rensen PCN, et al.
Lancet. Pub. online 6 Nov 2025.

Leggi

Novembre 13, 2025 Alice Lione

Associations between gestational diabetes and cardiovascular disease largely operate independently of postpartum causal pathways: a population-based cohort study in England

Astbury NM, Ripullone K, Ramakrishnan R, et al.
Diabetes Obes Metab. Pub. online 5 Nov 2025.

Leggi

Novembre 13, 2025 Alice Lione

Amylin and the renin-angiotensin system: risk or opportunity in amylin-based therapy?

Muskiet MHA, Nardone M, Rensen PCN, et al.
Lancet. Pub. online 6 Nov 2025.

Leggi

Novembre 13, 2025 Alice Lione

Survodutide for treatment of obesity: baseline characteristics of participants in a randomized, double-blind, placebo-controlled, phase 3 trial (SYNCHRONIZE™-1)

le Roux CW, Wharton S, Bozkurt B, et al.
Diabetes Obes Metab. Pub. online 4 Nov 2025.

Leggi

Novembre 13, 2025 Alice Lione

Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial

Billings LK, Hsia S, Bays H, et al.
Lancet. Pub. online 6 Nov 2025.

Leggi

Novembre 10, 2025 Alice Lione

Safety and pharmacokinetics of teplizumab in children less than 8 years of age with stage 2 type 1 diabetes

Gitelman SE, Simmons K, Sherr JL, et al.
Diabetologia. Pub. online 6 Nov 2025.

Leggi

Novembre 10, 2025 Alice Lione

Synergistic associations of metformin and GLP-1 receptor agonist use with adiposity-related cancer incidence in people living with type 2 diabetes

Henney AE, Heague M, Riley DR, et al.
Diabetes Obes Metab. Pub. online 3 Nov 2025.

Leggi

Novembre 6, 2025 Alice Lione

Screening natriuretic peptide levels predicts heart failure and death in individuals with type 1 and type 2 diabetes without known heart failure

Pop-Busui R, Repetto E, Baron J, et al.
Diabetes Care. Pub. online 30 Oct 2025.

Leggi